Stocks
Exact Sciences Corporation

Exact Sciences CorporationEXAS

NASDAQHealthcareBiotechnology$103.57+0.29%

Price as of · delayed, not real-time

A molecular diagnostics company focused on early cancer detection, best known for its Cologuard colorectal cancer screening test. The firm combines DNA and biomarker analysis with clinical risk factors to improve diagnostic accuracy, attracting investor attention as a leader in non-invasive cancer testing.

Market Cap: $19.8B52W Range: $38.81-$103.75

Congressional Interest in Exact Sciences Corporation (EXAS)

7 members of Congress have disclosed 36 trades in Exact Sciences Corporation (EXAS), a Healthcare company. The buy/sell breakdown shows 16 purchases versus 20 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
36
Unique Politicians
7
Buys
16
Sells
20

Who in Congress Is Trading EXAS?

2026-03-24$1K-$15K
Stock
2024-10-05$1K-$15K
Stock
2024-05-10$1K-$15K
Stock
2024-02-01$1K-$15K
Stock
2024-01-02$1K-$15K
Stock
2024-01-02$1K-$15K
Stock
2023-11-13$1K-$15K
Stock
2023-10-16$1K-$15K
Stock
2023-09-15$1K-$15K
Stock
2023-05-01$1K-$15K
Stock
2023-01-31$1K-$15K
Stock
2023-01-20$1K-$15K
Stock
2022-12-19$50K-$100K
Stock
2022-05-16$1K-$15K
Stock
2021-06-03$1K-$15K
Stock
2021-05-20$1K-$15K
Stock
2021-05-20$1K-$15K
Stock
2021-05-20$50K-$100K
Stock
2021-05-20$1K-$15K
Stock
2020-11-11$1K-$15K
Stock
2020-10-26$1K-$15K
Stock
2020-09-15$1K-$15K
Stock
2020-07-27$1K-$15K
Stock
2020-07-08$15K-$50K
Stock
2020-06-05$1K-$15K
Stock
2020-06-02$1K-$15K
Stock
2020-03-16$1K-$15K
Stock
2020-01-22$1K-$15K
Stock
2020-01-10$1K-$15K
Stock
2019-12-10$1K-$15K
Stock
2019-09-16$1K-$15K
Stock
2019-06-24$1K-$15K
Stock
2019-06-19$1K-$15K
Stock
2019-05-10$1K-$15K
Stock
2018-01-30$1K-$15K
Stock
2016-11-08$1K-$15K
Stock